Article citationsMore>>

Pharma, R. (2024). Rocket Pharmaceuticals Receives Orphan Medicinal, Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmyogenic Cardiomyopathy.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top